来自Lycoperdon pyriforme Schaeff的β-D-Glucan的隔离,特征和伤口愈合潜力
Elif Yavuz-Dokgöz1, Meltem Güleç2,3, Burçin İzbudak4
1Department of Biochemistry, Faculty of Pharmacy, Istinye University, Sariyer, 34396, Istanbul, Türkiye.
ChemistryOpen
|July 28, 2025
概括
这项研究从Lycoperdon pyriforme中分离了β-D-葡萄糖,发现它对伤口愈合安全有效. 该化合物表现出非有毒,血液相容性和促进凝血的特性,暗示了治疗潜力.
科学领域:
- 生物化学 生物化学
- 药理学 药理学 是一个学科.
- 菌类学 菌类学是指菌类学.
背景情况:
- 越来越多地因其药用特性而被认可,并且是科学研究的主题.
- β-D-葡萄糖是生物活性多糖,在具有多种生物活动的真菌中发现.
- 一种类型的Lycoperdon pyriforme在替代医学中具有潜在的应用.
研究的目的:
- 从Lycoperdon pyriforme中分离,净化和表征β-D-葡萄糖.
- 为了研究分离的β-D-葡萄糖的伤口愈合潜力.
- 评估β-D-葡萄糖的安全性和生物相容性.
主要方法:
- 隔离和净化β-D-葡萄糖.
- 使用凝浸透色谱 (GPC),里埃变换红外光谱 (FTIR) 和核磁共振 (NMR) 光谱进行了表征.
- 在实验室中对NIH 3T3细胞进行细胞毒性测试,用于表面形态的电子显微镜和血液溶解活性测试.
主要成果:
- 光谱分析证实了纯化的β-D-葡萄糖中存在β-(1→3) 和β-(1→6) 联系,表明了多分散性.
- 细胞毒性测定没有显示对NIH 3T3细胞产生不良影响,高达1000μg/mL.
- 较低度 (20-500μg/mL) 在体外显著促进细胞迁移和伤口关闭,溶血活性低于5%.
结论:
- 从Lycoperdon pyriforme中分离的β-D-葡萄糖是无毒的,并且与血液相容.
- 该化合物通过促进细胞迁移和伤口关闭而表现出治疗伤口的特性.
- 来自Lycoperdon pyriforme的β-D-glucan在伤口愈合应用中表现有前途,因此需要进一步研究其机制和临床疗效.
相关概念视频
Archaeal Cell Wall
Archaeal cell walls are structurally and compositionally distinct from their bacterial counterparts, lacking the characteristic peptidoglycan layer found in most bacteria. Instead, archaeal cell walls exhibit remarkable diversity, utilizing materials such as pseudomurein, polysaccharides, and proteins to construct their protective outer layers. This structural flexibility is closely tied to archaea's ecological adaptability.S-Layers: The Common Archaeal Cell WallThe S-layer is the most...
Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...


